Literature DB >> 8163786

Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases.

J F Tomee1, H F Kauffman, A H Klimp, J G de Monchy, G H Köeter, A E Dubois.   

Abstract

BACKGROUND: Despite increasing evidence implicating fungal proteases in the virulence of pulmonary fungal diseases, routine fungal culture media do not favor protease production. Hence, filtrates that serve as the source of antigen for serologic determinations are poor in proteases, and consequently, the immunologic significance of these enzymes is unknown.
METHODS: A clinical isolate of Aspergillus fumigatus was cultured on collagen medium, resulting in excretion of high levels of fungal proteases in the culture filtrate. This was compared with standard culture filtrates by diverse analytic techniques including immunoblotting with sera of patients with pulmonary aspergilloma (PA) and allergic bronchopulmonary aspergillosis (ABPA).
RESULTS: Protein profiles of collagen medium filtrate showed several (glyco)proteins not found in conventional culture filtrates, including a prominent 32 kd glycoprotein, which coisolated in gel filtration and ion-exchange chromatography with elastase activity, as well as 67 kd and 94 kd (glyco)proteins. Intense IgG binding was seen with the 32 kd glycoprotein when ABPA and PA sera were used. The 94 kd protein showed intense binding with PA sera but not with ABPA sera, whereas for the 67 kd glycoprotein the reverse tended to be the case.
CONCLUSION: Fungal culture on collagen media results in the production of filtrates with high protease activity, containing unique (glyco)proteins of which at least one (32 kd) is closely associated with fungal elastase activity. These constituents are immunologically relevant, eliciting IgG production in patients with PA and ABPA, suggesting production of these (glyco)proteins during disease in vivo. The use of collagen media filtrates may enhance our serodiagnostic capacity in patients with fungal pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163786     DOI: 10.1016/0091-6749(94)90257-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Zinc-regulated biosynthesis of immunodominant antigens from Aspergillus spp.

Authors:  M Segurado; R López-Aragón; J A Calera; J M Fernández-Abalos; F Leal
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

3.  Identification of 45 kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis.

Authors:  T Madan; B Banerjee; P K Bhatnagar; A Shah; P U Sarma
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 4.  Fungal proteases and their pathophysiological effects.

Authors:  Iwona Yike
Journal:  Mycopathologia       Date:  2011-01-23       Impact factor: 2.574

5.  Ribonuclease activity dependent cytotoxicity of Asp fl, a major allergen of A. fumigatus.

Authors:  T Madan; N Arora; P U Sarma
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

Review 6.  Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis.

Authors:  Alan P Knutsen; Raymond G Slavin
Journal:  Clin Dev Immunol       Date:  2011-04-05

7.  Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis.

Authors:  Alan P Knutsen
Journal:  J Allergy (Cairo)       Date:  2011-09-28

8.  A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis.

Authors:  Ritesh Agarwal; Durga Devi; Dheeraj Gupta; Arunaloke Chakrabarti
Journal:  Lung India       Date:  2014-07

Review 9.  Collagenolytic enzymes produced by fungi: a systematic review.

Authors:  Maria Carolina de Albuquerque Wanderley; José Manoel Wanderley Duarte Neto; José Luiz de Lima Filho; Carolina de Albuquerque Lima; José António Couto Teixeira; Ana Lúcia Figueiredo Porto
Journal:  Braz J Microbiol       Date:  2016-09-30       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.